Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal tranexamic acid vs microneedling plus topical tranexamic acid for melasma
IRCT20201205049603N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in melasma (2 arms), sponsored by Isfahan University of Medical Sciences. Started Nov 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20201205049603N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201205049603N1.